GSK plc 6-K, filed May 3, 2023
GSK plc (GSK)
6-K
2023-05-03
For: 2023-05-03
View Original
Added on
April 10, 2026
About this 6-K
GSK plc filed this 6-K on May 3, 2023.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR
15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the
month of May 2023
Commission
File Number 001-15170
GSK plc
(Translation
of registrant's name into English)
980 Great West Road, Brentford, Middlesex, TW8 9GS
(Address
of principal executive office)
Indicate
by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F.
Form
20-F . . . .X. . . . Form 40-F . . . . . . . .
GSK plc
Results of 23rd Annual General Meeting
GSK plc ('GSK') held a hybrid Annual General Meeting ('AGM') at
2.30pm on Wednesday 3 May 2023 at the Sofitel Hotel in Terminal 5
Heathrow. Shareholders were able to join the meeting in person or
virtually via the Lumi AGM website.
All valid proxy votes (whether submitted electronically or in hard
copy form) were included in the poll taken at the
meeting.
The table below shows the results of the poll on all 23
resolutions. The full text of the resolutions is contained in the
Notice of AGM published on 27 March 2023, which is available on
GSK's website at www.gsk.com.
|
Resolution
|
Total votes for(1)(2)
|
%
|
Total votes against(2)
|
%
|
Total votes cast
|
Votes withheld(3)
|
|
|
1
|
Receive and adopt the 2022 Annual Report
|
2,838,286,554
|
99.05
|
27,282,840
|
0.95
|
2,865,569,394
|
11,463,434
|
|
2
|
Approve the Annual report on remuneration
|
2,493,636,361
|
88.84
|
313,256,226
|
11.16
|
2,806,892,587
|
70,129,301
|
|
3
|
Election of Julie Brown
|
2,857,379,637
|
99.59
|
11,814,146
|
0.41
|
2,869,193,783
|
7,831,272
|
|
4
|
Election of Dr Vishal Sikka
|
2,860,647,976
|
99.69
|
8,837,033
|
0.31
|
2,869,485,009
|
7,534,298
|
|
5
|
Election of Elizabeth McKee Anderson
|
2,744,478,188
|
95.64
|
125,073,699
|
4.36
|
2,869,551,887
|
7,475,279
|
|
6
|
Re-election of Sir Jonathan Symonds
|
2,774,824,580
|
96.72
|
94,170,389
|
3.28
|
2,868,994,969
|
8,020,637
|
|
7
|
Re-election of Dame Emma Walmsley
|
2,862,165,104
|
99.74
|
7,358,771
|
0.26
|
2,869,523,875
|
7,508,911
|
|
8
|
Re-election of Charles Bancroft
|
2,786,237,098
|
97.24
|
79,167,334
|
2.76
|
2,865,404,432
|
11,602,033
|
|
9
|
Re-election of Dr Hal Barron
|
2,845,192,710
|
99.17
|
23,938,850
|
0.83
|
2,869,131,560
|
7,896,993
|
|
10
|
Re-election of Dr Anne Beal
|
2,788,179,755
|
97.17
|
81,326,824
|
2.83
|
2,869,506,579
|
7,517,274
|
|
11
|
Re-election of Dr Harry C Dietz
|
2,863,558,514
|
99.83
|
4,932,171
|
0.17
|
2,868,490,685
|
8,534,053
|
|
12
|
Re-election of Dr Jesse Goodman
|
2,863,346,622
|
99.79
|
6,079,498
|
0.21
|
2,869,426,120
|
7,596,197
|
|
13
|
Re-election of Urs Rohner
|
2,627,550,485
|
91.58
|
241,613,171
|
8.42
|
2,869,163,656
|
7,856,370
|
|
14
|
Re-appointment of the auditor
|
2,846,403,783
|
99.86
|
4,095,644
|
0.14
|
2,850,499,427
|
26,524,596
|
|
15
|
Remuneration of the auditor
|
2,865,552,679
|
99.83
|
4,889,379
|
0.17
|
2,870,442,058
|
6,575,928
|
|
16
|
Approve amendments to the Directors' Remuneration
Policy
|
2,837,886,999
|
99.01
|
28,431,513
|
0.99
|
2,866,318,512
|
10,705,019
|
|
17
|
Authority for the company to make donations to political
organisations and incur political expenditure
|
2,778,351,786
|
98.69
|
36,846,645
|
1.31
|
2,815,198,431
|
61,881,372
|
|
18
|
Authority to allot shares
|
2,749,592,663
|
95.85
|
118,984,091
|
4.15
|
2,868,576,754
|
8,438,938
|
|
19
|
Disapplication of pre-emption rights - general
power(4)
|
2,774,457,577
|
96.79
|
91,974,467
|
3.21
|
2,866,432,044
|
10,561,299
|
|
20
|
Disapplication of pre-emption rights - in connection with an
acquisition or specified capital investment(4)
|
2,747,347,831
|
95.84
|
119,258,296
|
4.16
|
2,866,606,127
|
10,393,035
|
|
21
|
Authority for the company to purchase its own
shares(4)
|
2,821,937,695
|
98.36
|
47,051,419
|
1.64
|
2,868,989,114
|
8,025,806
|
|
22
|
Exemption from statement of senior statutory auditor's
name
|
2,856,668,700
|
99.67
|
9,373,459
|
0.33
|
2,866,042,159
|
10,967,927
|
|
23
|
Authority for reduced notice of a general meeting other than an
AGM(4)
|
2,698,567,258
|
94.08
|
169,932,106
|
5.92
|
2,868,499,364
|
8,505,572
|
Notes:
(1)
The "for" votes include those giving the Chair
discretion.
(2)
Votes "for" and "against" are expressed as a percentage of the
total votes cast.
(3)
A "vote withheld" is not a vote in law and is not counted in the
calculation of the proportion of votes "for" or "against" a
resolution.
(4)
Indicates Special Resolutions requiring a 75% majority of votes
cast.
The following table provides further information on participation
in the AGM:
|
|
GSK's 23rd AGM
(Hybrid meeting)
(2023)
|
GSK's 22nd AGM
(Hybrid meeting)
(2022)
|
|
Issued share capital (excluding Treasury Shares)
|
4,094,980,743
|
5,083,974,547
|
|
Total votes cast and votes withheld lodged as a % of GSK's issued
share capital (excluding Treasury Shares)
|
70.26%
|
70.25%
|
|
Total shareholder population
|
63,362
|
89,764
|
|
Total number of proxies lodged
|
3,162
|
5,343
|
|
Number of shareholders in attendance
|
72 in person
49 participated virtually
|
93 in person
68 participated virtually
|
|
% of shareholders who lodged proxies
|
4.99%
|
5.95%
|
The above poll results will shortly be available on the company's
website at www.gsk.com.
In accordance with Listing Rule 9.6.2 of the Financial Conduct
Authority's (FCA) Listing Rules, a copy of the resolutions, other
than those concerning ordinary business, will be submitted to the
FCA and will in due course be available for inspection
at https://data.fca.org.uk/#/nsm/nationalstoragemechanism
V A Whyte
Company Secretary
3 May 2023
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorised.
|
|
GSK plc
|
|
|
(Registrant)
|
|
|
|
|
Date: May
03, 2023
|
|
|
|
|
|
|
By:/s/ VICTORIA
WHYTE
--------------------------
|
|
|
|
|
|
Victoria Whyte
|
|
|
Authorised
Signatory for and on
|
|
|
behalf
of GSK plc
|